Shukra [SHUKRAPHAR] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison

Shukra

BSE
Loading...

Aarti Drugs

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Shukra wins in 9 metrics, Aarti Drugs wins in 11 metrics, with 0 ties. Aarti Drugs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricShukraAarti DrugsBetter
P/E Ratio (TTM)265.0023.66Aarti Drugs
Price-to-Book Ratio24.613.26Aarti Drugs
Debt-to-Equity Ratio6.6544.92Shukra
PEG Ratio3.240.37Aarti Drugs
EV/EBITDA98.3217.07Aarti Drugs
Profit Margin (TTM)25.68%7.80%Shukra
Operating Margin (TTM)25.25%10.11%Shukra
EBITDA Margin (TTM)25.25%10.11%Shukra
Return on Equity15.24%12.28%Shukra
Return on Assets (TTM)11.04%6.53%Shukra
Free Cash Flow (TTM)$51.75M$674.22MAarti Drugs
Dividend Yield3.20%0.22%Shukra
1-Year Return364.29%-4.79%Shukra
Price-to-Sales Ratio (TTM)38.291.84Aarti Drugs
Enterprise Value$17.66B$50.47BAarti Drugs
EV/Revenue Ratio44.812.08Aarti Drugs
Gross Profit Margin (TTM)85.71%36.77%Shukra
Revenue per Share (TTM)$1$265Aarti Drugs
Earnings per Share (Diluted)$0.13$20.63Aarti Drugs
Beta (Stock Volatility)0.470.12Aarti Drugs
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Shukra vs Aarti Drugs Stock Performance Analysis

Loading Price Chart...

Shukra
Aarti Drugs
Shukra Stock Overview | Aarti Drugs Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Shukra-1.99%-0.09%23.88%107.66%67.40%140.74%
Aarti Drugs0.73%4.61%0.24%1.59%41.06%7.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Shukra364.29%579.49%2,326.06%2,066.67%828.57%828.57%
Aarti Drugs-4.79%-0.89%-50.06%219.30%2,690.01%2,872.19%

News Based Sentiment: Shukra vs Aarti Drugs

Shukra

News based Sentiment: MIXED

September presented a mixed bag for Shukra Pharmaceuticals. While the company achieved a new 52-week high and secured a significant distribution partnership with Wockhardt, it also reported a substantial revenue contraction in FY25. The upcoming warrant issue adds another layer of complexity, making it a pivotal month for the company's future direction.

View Shukra News Sentiment Analysis

Aarti Drugs

News based Sentiment: POSITIVE

Aarti Drugs reported substantial profit growth in both Q1FY26 and FY2025, coupled with increased institutional interest from Mutual Funds. While shareholding changes and recent price volatility exist, the overall narrative points towards a strengthening investment case.

View Aarti Drugs News Sentiment Analysis

Performance & Financial Health Analysis: Shukra vs Aarti Drugs

MetricSHUKRAPHARAARTIDRUGS
Market Information
Market Cap i₹15.39B₹44.55B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i125,008201,942
90 Day Avg. Volume i353,040187,563
Last Close₹34.45₹491.60
52 Week Range₹5.75 - ₹35.86₹312.00 - ₹564.05
% from 52W High-3.93%-12.84%
All-Time High₹35.86 (Sep 30, 2025)₹1,026.95 (Oct 05, 2020)
% from All-Time High-3.93%-52.13%
Growth Metrics
Quarterly Revenue Growth0.67%0.06%
Quarterly Earnings Growth1.12%0.62%
Financial Health
Profit Margin (TTM) i0.26%0.08%
Operating Margin (TTM) i0.25%0.10%
Return on Equity (TTM) i0.15%0.12%
Debt to Equity (MRQ) i6.6544.92
Cash & Liquidity
Book Value per Share (MRQ)₹1.40₹149.84
Cash per Share (MRQ)₹0.24₹2.48
Operating Cash Flow (TTM) i₹66.80M₹2.83B
Levered Free Cash Flow (TTM) i₹95.75M₹1.68B
Dividends
Last 12-Month Dividend Yield i3.20%0.22%
Last 12-Month Dividend i₹1.02₹1.00

Valuation & Enterprise Metrics Analysis: Shukra vs Aarti Drugs

MetricSHUKRAPHARAARTIDRUGS
Price Ratios
P/E Ratio (TTM) i265.0023.66
Forward P/E iN/A15.02
PEG Ratio i3.240.37
Price to Sales (TTM) i38.291.84
Price to Book (MRQ) i24.613.26
Market Capitalization
Market Capitalization i₹15.39B₹44.55B
Enterprise Value i₹17.66B₹50.47B
Enterprise Value Metrics
Enterprise to Revenue i44.812.08
Enterprise to EBITDA i98.3217.07
Risk & Other Metrics
Beta i0.470.12
Book Value per Share (MRQ) i₹1.40₹149.84

Financial Statements Comparison: Shukra vs Aarti Drugs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SHUKRAPHARAARTIDRUGS
Revenue/Sales i₹53.91M₹5.91B
Cost of Goods Sold i₹7.70M₹3.73B
Gross Profit i₹46.21M₹2.17B
Research & Development iN/AN/A
Operating Income (EBIT) i₹5.32M₹593.60M
EBITDA i₹24.28M₹743.90M
Pre-Tax Income i₹13.73M₹511.10M
Income Tax i₹3.44M₹-28.60M
Net Income (Profit) i₹10.30M₹539.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SHUKRAPHARAARTIDRUGS
Cash & Equivalents i₹121.18M₹45.77M
Total Current Assets i₹654.27M₹13.38B
Total Current Liabilities i₹172.84M₹8.37B
Long-Term Debt i₹31.13M₹2.86B
Total Shareholders Equity i₹628.36M₹13.69B
Retained Earnings i₹143.00M₹12.40B
Property, Plant & Equipment i₹193.97M₹27.03M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SHUKRAPHARAARTIDRUGS
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSHUKRAPHARAARTIDRUGS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i125,008201,942
Average Daily Volume (90 Day) i353,040187,563
Shares Outstanding i437.88M91.27M
Float Shares i54.95M39.04M
% Held by Insiders i0.89%0.60%
% Held by Institutions i0.00%0.11%

Dividend Analysis & Yield Comparison: Shukra vs Aarti Drugs

MetricSHUKRAPHARAARTIDRUGS
Last 12-Month Dividend i₹1.02₹1.00
Last 12-Month Dividend Yield i3.20%0.22%
3-Year Avg Annual Dividend i₹0.35₹1.00
3-Year Avg Dividend Yield i3.91%0.23%
3-Year Total Dividends i₹1.05₹3.00
Ex-Dividend DateSep 23, 2025Feb 04, 2025